Abstract
IgA Nephropathy (IgAN), the major primary glomerulonephritis (GN) worldwide, is characterized by the mesangial deposition of IgA1-containing complexes (Monteiro et al., 2002). This apparently benign condition was revealed to be a major health problem due to the fact that around 25 to 40% of patients progress to end-stage renal disease following 20 years of disease onset (Coppo and D'Amico…
